Red Light Therapy for Myopia in Children: How It Works, What the Evidence Shows and the Safety Debate
Last updated: November 2026
Key points in 60 seconds
Repeated low-level red light (RLRL) therapy uses a desktop device that shines red light (about 650 nm) into the eyes for 3 minutes, twice a day.
Trials, mostly in China, show it slows the growth of myopia and eye length over 1 to 2 years, with some rebound when it is stopped.
Laboratory tests in 2025 found some devices exceed eye safety limits within seconds, and retinal damage has been reported in rare cases.
If used, it should be under an eye doctor, with retinal scans (OCT) before and during treatment; never use red light panels or beauty masks for this.
Low-dose atropine, myopia control spectacle lenses, special contact lenses and outdoor time have longer safety records.
Red light therapy for myopia has become one of the most talked-about treatments in children's eye care. Parents see it on social media and ask about it in clinic. Here is what it is, what the trials show, and why eye doctors are cautious.
What is it?
A desktop device shines low-level red light, usually from a laser diode at about 650 nm, into the eyes.
The child looks into the device for 3 minutes, twice a day with at least 4 hours between sessions, usually 5 days a week.
The exact mechanism is unknown. Theories include increased blood flow in the choroid (the vascular layer under the retina), which thickens after treatment, and effects on retinal signals that control eye growth.
What the evidence shows
Finding
Detail
Effect on myopia
Randomised trials in China found slower progression in spherical equivalent and slower axial elongation over 1 year compared with single-vision glasses; some children showed axial shortening
Longer term
Two-year data suggest the effect continues, but fewer studies exist beyond that
Rebound
When treatment stops, myopia progression and eye growth may speed up again
Who was studied
Mostly Chinese children aged about 6 to 13; less is known for other populations
LED devices
LED-based devices have not yet been proven effective in clinical trials
Safety concerns
Retinal injury: case reports have described damage to the central retina (photoreceptor layer) after RLRL use, some with reduced vision.
Device output varies: a 2025 laboratory study in JAMA Ophthalmology measured four devices. One exceeded the Class 1 laser limit, and two exceeded the safe "Group 1" limit for ophthalmic light within 1.4 and 2.8 seconds, much less than a 3-minute session. An LED device stayed within limits for hours.
Afterimages: children often see an afterimage after each session; one that lasts longer than a few minutes is a reason to stop.
Regulation: approval and regulation differ by country, and China has moved to regulate these devices more tightly. Check whether a device is approved by your country's medical device regulator before using it.
Do not improvise. Red light therapy panels, beauty face masks, laser pointers and phone apps are not myopia treatments and can harm the retina.
How it compares with other myopia control options
Option
Effect
Safety record
Outdoor time (about 2 hours a day)
Delays onset of myopia
Excellent
Low-dose atropine drops (0.01% to 0.05%)
Slows progression; higher strengths work better
Long record; mild glare or near blur
Myopia control spectacle lenses (for example DIMS, HAL designs)
Slows progression
Very safe
Myopia control soft contact lenses and orthokeratology
Slows progression and eye growth
Good with proper hygiene; small infection risk
Repeated low-level red light
Strong short-term effect in trials
Limited long-term data; device safety concerns
If your child is offered red light therapy
Ask whether the device is approved by your national regulator and what its output is.
Insist on a full eye examination with retinal OCT before starting, and repeat OCT at regular visits.
An adult should supervise every session; use the exact time and distance stated.
Stop and see the eye doctor if the child reports a lasting afterimage, blurred central vision or a dark spot.
Jiang Y, Zhu Z, Tan X, et al. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology. 2022;129:509-519
Liu H, Yang Y, Guo J, et al. Retinal damage after repeated low-level red-light laser exposure. JAMA Ophthalmol. 2023;141:693-695
Ostrin LA, Schill AW, et al. Optical radiation safety of red-light therapy devices for myopia control. JAMA Ophthalmol. 2025
Healio. Some red light therapy devices for myopia control may exceed safe exposure limits. 30 June 2026
International Myopia Institute. White papers on myopia management
Patel D. Red Light Therapy for Myopia in Children: How It Works, What the Evidence Shows and the Safety Debate. RPC Rounds (Sadbhaav Eye Clinic). Updated November 2026. Available at: https://www.sadbhaavclinic.com/red-light-therapy-myopia-children.html. Accessed [date].
Written and medically reviewed by Dr. Dhaval Patel, MD (Ophthalmology, AIIMS New Delhi) · Editorial policy